Recent studies showed that the nonmucinous ACs had a higher tumor derived MMP13 protein levels than MACs and SCs, which are more invasive and have a higher frequency of lymph node metastasis than nonmucinous ACs [41]. The gene discussed is MMP13; the disease is metastatic malignant neoplasm in the lymph nodes.